Case 38-2005: A 29-year-old pregnant woman with the nephrotic syndrome and hypertension

New England Journal of Medicine

Volumn 353, Issue 24, 2005, Pages 2590-2600

  Williams Jr , Winfred W ^a,b   Ecker, Jeffrey L ^a,b   Thadhani, Ravi I ^a,b   Rahemtullah, Aliyah ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; ENALAPRIL; FUROSEMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN; PLACENTA PROTEIN; PRODUCT PLACENTA GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CASE REPORT; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; LABORATORY TEST; LUPUS ERYTHEMATOSUS NEPHRITIS; NEPHROLOGY; NEPHROTIC SYNDROME; PREECLAMPSIA; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; SEXUAL INTERCOURSE; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; CLINICAL CHEMISTRY; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; KIDNEY; MALE; MATERNAL HYPERTENSION; NEWBORN; PATHOLOGY; PLACENTA; PREGNANCY COMPLICATION;

ADULT; BIOLOGICAL MARKERS; CLINICAL CHEMISTRY TESTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INFANT, NEWBORN; KIDNEY; KIDNEY FAILURE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; NEPHROTIC SYNDROME; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 28944445321     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc059031     Document Type: Article

References (21)

1. Moroni G, Ponticelli C. The risk of pregnancy with lupus nephritis. J Nephrol 2003;16:161-7.
2. Sibai B, Dekker G, Kupermin C. Preeclampsia. Lancet 2005;365:785-99.
3. Lockshin MD. Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 1989;32:665-70.
4. Moroni G, Quaglini S, Banfi G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis 2002;40:713-20.
5. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy: the Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 1991;34:1538-45.
6. Hayslett JP, Lynn RI. Effect of pregnancy in patients with lupus nephropathy. Kidney Int 1980;18:207-20.
7. Imbasciati E, Surian M, Bottino S, et al. Lupus nephropathy and pregnancy: a study of 26 pregnancies in patients with systemic lupus erythematosus and nephritis. Nephron 1984;36:46-51.
8. Meola M, Barsotti G, Cupisti A, Buoncristiani E, Giovannetti S. Free-hand ultrasound-guided renal biopsy: report of 650 consecutive cases. Nephron 1994;67:425-30.
9. Chen HH, Lin HC, Yeh JC, Chen CP. Renal biopsy in pregnancies complicated by undetermined renal disease. Acta Obstet Gynecol Scand 2001;80:888-93.
10. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241-50. [Erratum, J Am Soc Nephrol 2004;15:835-6.]
11. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65:521-30. [Erratum, Kidney Int 2004;65:1132.]
12. Labarrere CA, Catoggio LJ, Mullen EG, Althabe OH. Placental lesions in maternal autoimmune diseases. Am J Reprod Immunol Microbiol 1986;12:78-86.
13. Magid MS, Kaplan C, Sammaritano LR, Peterson M, Druzin ML, Lockshin MD. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 1998;179:226-34.
14. Ogishima D, Matsumoto T, Nakamura Y, Yoshida K, Kuwabara Y. Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies. Pathol Int 2000;50:224-9.
15. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002;2:656-63. [Erratum, Nat Rev Immunol 2002;2:975.]
16. Guzman L, Avalos E, Ortiz R, Gurrola R, Lopez E, Herrera R. Placental abnormalities in systemic lupus erythematosus: in situ deposition of antinuclear antibodies. J Rheumatol 1987;14:924-9.
17. Hanly JG, Gladman DD, Rose TH, Laskin CA, Urowitz MB. Lupus pregnancy: a prospective study of placental changes. Arthritis Rheum 1988;31:358-66.
18. Labarrere C, Alonso J, Manni J, Domenichini E, Althabe O. Immunohistochemical findings in acute atherosis associated with intrauterine growth retardation. Am J Reprod Immunol Microbiol 1985;7:149-55.
19. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111:649-58.
20. Thadhani R, Mutter WP, Wolf M, et al. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004;89:770-5.
21. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83.